Search results

This article is over 5 years old, and the information may therefore be outdated. Alzheimer's disease is characterized by the abnormal accumulation and spread of the tau protein in the brain. An international study can now show how tau spreads according to four distinct patterns that lead to different symptoms with different prognoses of the affected individuals. The study was published in Nature M

https://www.multipark.lu.se/article/alzheimers-disease-composed-four-distinct-subtypes - 2026-05-09

This article is over 5 years old, and the information may therefore be outdated. On May 11, it is time for the first of a total of six workshops concerning the strategic research areas’ (SRA) work on sustainable development. Sustainability is more than climate and environmental issues. Goal number 3 of the UN global sustainability goals focuses on “good health and well-being”. The workshop series

https://www.multipark.lu.se/article/workshop-series-sustainability-effect-research - 2026-05-09

Deep interviews with patients who are at an early stage of Parkinson’s disease show that acceptance was a prerequisite for a maintained life satisfaction despite the disease. The study was conducted by health science researchers from the strategic research area MultiPark at Lund University. People living with Parkinson's disease deal with symptoms and impairments due to the progression of the dise

https://www.multipark.lu.se/article/acceptance-key-life-satisfaction-persons-parkinsons-disease - 2026-05-09

Distinguishing taupathies by kinetic analysis of reproducibility-optimized RT-quic experiments - Alexander DearPersonalized diagnosis and prognosis of Alzheimer´s disease - O Hansson, N Mattsson-Carlgren, S PalmqvistThe Alzheimer patient’s clinical cell biology - Hansson, Parmar, ToressonA new drug screening strategy for Huntington’s disease using induced neurons - Johan JakobssonPathophysiology-g

https://www.multipark.lu.se/innovation/innovation-projects-supported-multipark - 2026-05-09

Nine senior researchers from five different faculties at Lund University have been granted three million SEK for a novel transdisciplinary initiative to improve the early diagnosis of Alzheimer’s disease. Four of them are research leaders from the strategic research area MultiPark at the Medical Faculty. The collaboration also involves Region Skåne, Lund Municipality, and several important partner

https://www.multipark.lu.se/article/three-million-new-thematic-collaboration-initiative-about-early-diagnosis-and-prognostics-alzheimers - 2026-05-09

Researchers at Lund University in Sweden have developed an algorithm that combines data from a simple blood test and brief memory tests, to predict with great accuracy who will develop Alzheimer's disease in the future. The findings are published in Nature Medicine. Approximately 20-30% of patients with Alzheimer's disease are wrongly diagnosed within specialist healthcare, and diagnostic work-up

https://www.multipark.lu.se/article/simple-diagnostic-tool-predicts-individual-risk-alzheimers - 2026-05-09

During her Ph.D. studies, Yiyi Yang has been investigating the role of microglia in the pathological development of Alzheimer’s disease. On the 3rd of June, it is time to defend her work supervised by Prof. Tomas Deierborg. Now, Yiyi tells us about her research in the Experimental Neuroinflammation Laboratory as being a part of MultiPark. Can you tell us about your Ph.D. research? The focus of our

https://www.multipark.lu.se/article/phd-defence-interview-yiyi-yang - 2026-05-09

Around 20 000 Swedes are currently suffering from Parkinson’s disease, yet there are still only treatments to alleviate symptoms. Through a new biobank, researchers gain access to the genetic profiles of 1000 Parkinson’s patients together with comprehensive information about their lifestyles and medical histories. “I am convinced that many researchers will use the biobank over the next few years,

https://www.multipark.lu.se/article/new-biobank-provides-insights-parkinsons-disease - 2026-05-09

On the first of January, Professor Angela Cenci Nilsson took on as the new coordinator for MultiPark. Now she tells us about her visions for our network and about being a senior researcher in the environment. About the role as the new coordinator   I will do my best to foster collaborative projects with high scientific and/or translational potential.   What does being appointed to the new coordina

https://www.multipark.lu.se/article/interview-angela-cenci-nilsson-about-being-new-coordinator-multipark - 2026-05-09

Senior Researchers Ahlenius, Henrik - Stem Cells, Aging and NeurodegenerationBjörklund, Anders - affiliated with Developmental Neurobiology LabBjörklund, Tomas - Molecular Neuromodulation UnitBjörkqvist, Maria - Biomarkers in Brain DiseaseCenci Nilsson, Angela - Basal Ganglia PathophysiologyDeierborg, Tomas - NeuroinflammationEnglund, Elisabet - Division of Oncology and PathologyGouras, Gunnar - E

https://www.multipark.lu.se/research/research-groups - 2026-05-09

Our research We investigate how different parts of the central nervous system interact to generate purposeful behaviors. In particular, we study how the cerebral cortex and the basal ganglia interact to control motor actions, both under normal conditions and in individuals afflicted by Parkinson’s disease. In our previous work, we have studied motor control functions, ranging from relatively simpl

https://www.multipark.lu.se/integrative-neurophysiology-and-neurotechnology-lu-umu - 2026-05-09

T-cells, antibodies, and antigens. During the past year, we have learned a lot about our immune system through media. Most people agree that the immune system is crucial for our survival. But how does the immune system affect Parkinson’s disease; is it necessary to keep our brains healthy, or does it contribute to disease progression? The answer to that question is unfortunately not straightforwar

https://www.multipark.lu.se/article/does-our-immune-response-affect-risk-developing-parkinsons-disease - 2026-05-09

MultiPark offers travel grants to PhD students and postdocs, but not for group leaders, senior lecturers, docents and above. Maximum two travel grants per applicant per calendar year.Maximum 18 000 SEK (including indirect costs) per applicant per calendar year. Maximum award for digital events is 3 000 SEK (including indirect costs).If awarded a travel grant, the recipient must agree on:Giving a l

https://www.multipark.lu.se/funding-opportunities/travel-grants - 2026-05-09

Our research The brain´s basal ganglia elaborate information from multiple sources to shape and select our movements and thoughts. These functions are heavily dependent on signals that originate from dopamine cells in the midbrain. Dopamine cells degenerate in Parkinson´s disease (PD) giving rise to typical motor and non-motor deficits. With our research, we pursue pathophysiological mechanisms an

https://www.multipark.lu.se/basal-ganglia-pathophysiology - 2026-05-09

An experimental study from Lund University in Sweden has revealed that the Alzheimer’s protein amyloid-beta accumulates inside nerve cells, and that the misfolded protein may then spread from cell to cell via nerve fibres. This happens at an earlier stage than the formation of amyloid-beta plaques in the brain, something that is associated with the progression of Alzheimer’s disease. The study in

https://www.multipark.lu.se/article/does-alzheimers-disease-start-inside-nerve-cells - 2026-05-09

Other strategic grants give you the opportunity to obtain co-funding when inviting scientific guests to give lectures or when organizing scientific conferences. The granted amount can be used to cover travel and accommodation costs in connection with the event. Please indicate if food/drinks are requested and indicate an amount. Costs for subsistence allowance (“traktamente”) are not eligible. Tri

https://www.multipark.lu.se/funding-opportunities/other-strategic-grants - 2026-05-09

Our research Our projects focus is to investigate the role of neuroinflammation in neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease and stroke. Microglia are the major immune cells in the brain. Therefore, the majority of our projects aim to explore the function of these cells and to determine how they contribute to health and disease. In addition, we investigate how

https://www.multipark.lu.se/experimental-neuroinflammation-laboratory - 2026-05-09

Our research Dementia is a major public health concern globally but treatments have so far been inadequate. Our focus is to understand the early molecular and cellular pathology that we see initiating in synapses in Alzheimer’s disease, the most common neurodegenerative disease. It remains imperative that academic researchers uncover early steps in the disease process, rather than only translating

https://www.multipark.lu.se/experimental-dementia-research - 2026-05-09

Our research The human brain is a highly complex structure, consisting of hundreds of different subtypes of neurons; each of which fulfill a specific function in the brain network. When some of these neurons are lost – such as in neurodegenerative diseases – our brains become malfunctioning. The goal of our research is to develop stem cell-based therapies to replace lost neurons as a treatment for

https://www.multipark.lu.se/human-neural-development - 2026-05-09

Our research We develop new microfluidic and acoustofluidic technology to create spatially and temporally controlled microenvironments for cell culturing and to manipulate biological matter in the microscale. This will provide new strategies for stem cell differentiation, novel means to study cell/tissue drug response, and new techniques for cell separation as well as submicron particle separation

https://www.multipark.lu.se/nanobiotechnology-and-lab-chip - 2026-05-09